Navigation Links
Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
Date:11/12/2013

Portland, Maine (PRWEB) November 12, 2013

In July 2012, Maine Biotechnology Services entered into a partnership with Dr. Scott McVey, supervisor of the USDA-Agricultural Research Service (USDA-ARS) Arthropod Borne Animal Disease Research Unit, with the objective of developing monoclonal antibodies to support ongoing research efforts to advance adequate vaccine and rapid detection methods for Rift Valley Fever Virus in Africa. MBS is announcing the release of the first two antibodies resulting from that partnership; a functioning matched pair demonstrating specificity to the nucleocapsid protein of the virus. The antibodies have applications as detection reagents for circulating antigen, mosquito carriers, or as components of differentiation of infected and vaccinated animals (DIVA) assays. In the final phase of validation for the antibodies, Dr. McVey intends to deliver them to USDA-ARS partnered laboratories in South Africa and other endemic African nations for assay development with clinical samples. Future goals of the MBS-USDA-ARS Rift Valley Fever program include the development of antibodies to the Gn and NSs proteins to support vaccine programs.

About Rift Valley Fever Virus: Rift Valley Fever is a devastating virus transmitted by mosquitoes that affects both animals and humans. The disease results in significant economic losses due to death and abortion in RVFV infected livestock. Originating in the Rift Valley of Kenya, outbreaks of the virus now occur in all areas of sub-Saharan and North Africa. Cases have also been confirmed in Yemen and Saudi Arabia, causing widespread concern about the vulnerability of parts of Asia and Europe involved in livestock trade with Africa.

About Maine Biotechnology Services: Maine Biotechnology Services is a premier provider of antibody services, from design and development to production and characterization. MBS extends the creativity and experience necessary for the most complex hybridoma development projects. A wide variety of tools are utilized by MBS to allow customers the opportunity to refine clone selection early in a project, and to support prototype assay validation. Collaboration opportunities combine 25 years of custom hybridoma development experience at MBS with academic expertise on a target of shared interest.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11321207.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Maine Selects Advanced Kiosks as Supplier for Statewide Initiative
2. Maine Law Further Protects Health Care Providers in Preferred Provider Arrangements
3. Classe Wines Announces Availability of 2007 Domaine Du Pourra La Reserve Gigondas
4. Classe Wines Offers 2008 Pinot Noir Domaine Jean-Michel Guillon Les Crais in Limited Quantity
5. 2000 Domaine Barat Chablis Premier Cru "Les Fourneaux" Available in Limited Quantity from Classe Wines
6. Zane Benefits Publishes New Information on Maine Health Insurance Exchange
7. Premier Cru, Gem of French Winemaking Arrives in the United From Domaine Bzikot Made Available by Classe Wines
8. Policy Meets Practice at 23th Annual Maine Geriatrics Conference
9. University of Maine Football Completes Ground-Breaking Team Leadership and Emotional Intelligence Training Program
10. Vein Healthcare Center in South Portland, Maine Hosts Varicose Vein Seminar
11. High Schoolers Can 'Smile' While Exploring Dental Careers at Summer Camp in Maine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... April 01, 2020 , ... According to data released by Power ... in need of publicly funded contraception live in counties impacted by the implementation of ... have lost some or all of their Title X resources. , The domestic ...
(Date:3/30/2020)... , ... March 30, 2020 , ... ... and prospective patients, continuing its commitment to provide comprehensive and compassionate mental health ... can use Achieve Medical Center’s UpDox platform for telemedicine services including initial consultations, ...
(Date:3/28/2020)... ... March 27, 2020 , ... To help prevent the spread ... as an alternative approach to seeing their patients. This approach will allow patients ... their own home or office using video conference and telecommunications technology, such as ...
(Date:3/27/2020)... ... 2020 , ... On March 27th, 2020, Talos Health Solutions , kicked ... families and caregivers living in the US. This free online conference will be available ... and will focus on asthma symptoms, the different kinds of asthma, treatment options, the ...
(Date:3/22/2020)... ... 21, 2020 , ... TriageLogic, a leader in telephone nurse ... health centers can use for patient care during the COVID-19 crisis. , ... working around the clock to implement emergency support solutions for patients who present ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... ... April 02, 2020 , ... NCPDP has elected its 2020-2021 Board of Trustees. ... Board of Trustees on Wednesday, May 6, 2020. , Election Results – Newly ... Point-of-Care Partners, newly elected to the Board of Trustees. , Morgan Bojorquez, ...
(Date:4/1/2020)... , ... April 01, 2020 , ... ... market, is continuing her partnership with the esteemed Haute Beauty network. , The ... to present Dr. Green as a leading Anti-Aging Expert. , Haute Beauty offers ...
(Date:3/30/2020)... ... March 30, 2020 , ... ... employees, today announced it has launched a series of survey question packs that ... actionable feedback to inform mission-critical decisions. As the current situation continues to evolve, ...
Breaking Medicine Technology: